AstraZeneca has officially opened its new active pharmaceutical ingredient (API) manufacturing facility in Dublin, Ireland. IDA Ireland, the foreign direct investment arm of the Irish government, said in a news release that the new facility brings advanced automation, AI and innovative new technologies into one place to continue to innovate in science and manufacturing. “Healthcare…
Lilly expands manufacturing footprint in Ireland
Eli Lilly and Co. recently announced that it’s spending $1 billion to expand its Limerick, Ireland, manufacturing site. The goal of the expansion, announced Sept. 12, is to increase the production of biologic active ingredients, including those for the company’s recently approved treatment for early symptomatic Alzheimer’s disease. The company announced in July that the…